TY - JOUR
T1 - Structural studies of P-type ATPase-ligand complexes using an X-ray free-electron laser
AU - Bublitz, Maike
AU - Nass, Karol
AU - Drachmann, Nikolaj D.
AU - Markvardsen, Anders J.
AU - Gutmann, Matthias J.
AU - Barends, Thomas R.M.
AU - Mattle, Daniel
AU - Shoeman, Robert L.
AU - Doak, R. Bruce
AU - Boutet, Sébastien
AU - Messerschmidt, Marc
AU - Seibert, Marvin M.
AU - Williams, Garth J.
AU - Foucar, Lutz
AU - Reinhard, Linda
AU - Sitsel, Oleg
AU - Gregersen, Jonas L.
AU - Clausen, Johannes D.
AU - Boesen, Thomas
AU - Gotfryd, Kamil
AU - Wang, Kai Tuo
AU - Olesen, Claus
AU - Møller, Jesper V.
AU - Nissen, Poul
AU - Schlichting, Ilme
N1 - Publisher Copyright:
© 2015.
PY - 2015/7/1
Y1 - 2015/7/1
N2 - Membrane proteins are key players in biological systems, mediating signalling events and the specific transport of e.g. ions and metabolites. Consequently, membrane proteins are targeted by a large number of currently approved drugs. Understanding their functions and molecular mechanisms is greatly dependent on structural information, not least on complexes with functionally or medically important ligands. Structure determination, however, is hampered by the difficulty of obtaining well diffracting, macroscopic crystals. Here, the feasibility of X-ray free-electron-laser-based serial femtosecond crystallography (SFX) for the structure determination of membrane protein-ligand complexes using microcrystals of various native-source and recombinant P-type ATPase complexes is demonstrated. The data reveal the binding sites of a variety of ligands, including lipids and inhibitors such as the hallmark P-type ATPase inhibitor orthovanadate. By analyzing the resolution dependence of ligand densities and overall model qualities, SFX data quality metrics as well as suitable refinement procedures are discussed. Even at relatively low resolution and multiplicity, the identification of ligands can be demonstrated. This makes SFX a useful tool for ligand screening and thus for unravelling the molecular mechanisms of biologically active proteins.
AB - Membrane proteins are key players in biological systems, mediating signalling events and the specific transport of e.g. ions and metabolites. Consequently, membrane proteins are targeted by a large number of currently approved drugs. Understanding their functions and molecular mechanisms is greatly dependent on structural information, not least on complexes with functionally or medically important ligands. Structure determination, however, is hampered by the difficulty of obtaining well diffracting, macroscopic crystals. Here, the feasibility of X-ray free-electron-laser-based serial femtosecond crystallography (SFX) for the structure determination of membrane protein-ligand complexes using microcrystals of various native-source and recombinant P-type ATPase complexes is demonstrated. The data reveal the binding sites of a variety of ligands, including lipids and inhibitors such as the hallmark P-type ATPase inhibitor orthovanadate. By analyzing the resolution dependence of ligand densities and overall model qualities, SFX data quality metrics as well as suitable refinement procedures are discussed. Even at relatively low resolution and multiplicity, the identification of ligands can be demonstrated. This makes SFX a useful tool for ligand screening and thus for unravelling the molecular mechanisms of biologically active proteins.
KW - P-type ATPases
KW - XFEL
KW - ligand screening
KW - serial femtosecond crystallography
UR - http://www.scopus.com/inward/record.url?scp=84940875231&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84940875231&partnerID=8YFLogxK
U2 - 10.1107/S2052252515008969
DO - 10.1107/S2052252515008969
M3 - Article
AN - SCOPUS:84940875231
SN - 2052-2525
VL - 2
SP - 409
EP - 420
JO - IUCrJ
JF - IUCrJ
ER -